Business1 min read

Genmab nine-month revenue rises 22% as late-stage pipeline delivers

By · Via Investing.com Markets · Published by Everything Blog

In short

Genmab's revenue for the first nine months increased by 22 percent. The revenue growth comes as the company's late-stage pipeline continues to deliver results.

Key points

  • Genmab's revenue for the first nine months increased by 22 percent.: Genmab's revenue for the first nine months increased by 22 percent.
  • The revenue growth comes as the company's late-stage pipeline continues to deliver result…: The revenue growth comes as the company's late-stage pipeline continues to deliver results.
Business